ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F

April 24, 2018

LYON, France--(BUSINESS WIRE)--Apr. 24, 2018-- Regulatory News: ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases ba

Read More

Erytech: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – March 31, 2018

April 16, 2018

Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France--(BUSINESS WIRE)--Apr. 16, 2018-- Regulatory News: Erytech (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Eu

Read More